Cargando…

Anti-cytokine therapy in chronic destructive arthritis

Tumor necrosis factor (TNF) and interleukin-1 (IL-1) are considered to be master cytokines in chronic, destructive arthritis. Therapeutic approaches in rheumatoid arthritis (RA) patients have so far focused mainly on TNF, which is a major inflammatory mediator in RA and a potent inducer of IL-1; ant...

Descripción completa

Detalles Bibliográficos
Autor principal:	van den Berg, Wim B
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128880/ https://www.ncbi.nlm.nih.gov/pubmed/11178124 http://dx.doi.org/10.1186/ar136

Ejemplares similares

Role of Cytokines in Cartilage Destruction in Experimental Arthritis
por: van den Berg, Wim B
Publicado: (2000)

Response to Fionula Brennan's Commentary "A follow-up to 'Anti-cytokine therapy in chronic destructive arthritis' by Wim B van den Berg"
por: van den Berg, Wim B
Publicado: (2001)

The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models
por: Lubberts, Erik, et al.
Publicado: (2005)

Cytokine-Mediated Bone Destruction in Rheumatoid Arthritis
por: Jung, Seung Min, et al.
Publicado: (2014)

A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg
por: Brennan, Fionula M
Publicado: (2001)

Genome-wide gene expression in experimental arthritis: defining new targets of chronic/destructive rheumatoid arthritis (RA)
por: Takahashi, N, et al.
Publicado: (2002)

FcgammaR expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA)
por: Blom, Arjen B, et al.
Publicado: (2000)

Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?
por: van de Loo, Fons AJ, et al.
Publicado: (2004)

Lessons from animal models of arthritis over the past decade
por: Berg, Wim B van den
Publicado: (2009)

Exposure to Candida albicans Polarizes a T-Cell Driven Arthritis Model towards Th17 Responses, Resulting in a More Destructive Arthritis
por: Marijnissen, Renoud J., et al.
Publicado: (2012)

Local interleukin-12 gene transfer promotes conversion of an acute to a chronic destructive murine streptococcal cell wall arthritis
por: Joosten, LAB, et al.
Publicado: (2001)

Gene therapy of destructive arthritis in SCID mice
por: Sack, U, et al.
Publicado: (2003)

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis
por: Joosten, Leo AB, et al.
Publicado: (1999)

Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis
por: Wenink, Mark H, et al.
Publicado: (2011)

Bone morphogenetic proteins in destructive and remodeling arthritis
por: Lories, Rik JU, et al.
Publicado: (2007)

Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy
por: Venkatesha, Shivaprasad H., et al.
Publicado: (2014)

Requirement of IL-17 receptor signaling in resident synoviocytes for development of full blown destructive arthritis
por: Lubberts, E, et al.
Publicado: (2005)

Activating FcγRIII determines cartilage destruction during immune complex arthritis but not in the presence of T-cell immunity
por: van Lent, PLEM, et al.
Publicado: (2002)

Neutralizing synovial RANKL by local OPG gene therapy in collagen-induced arthritis prevents cartilage erosion through induction of a non-destructive type 2 synovitis
por: Lubberts, E, et al.
Publicado: (2004)

Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis
por: Mullazehi, Mohammed, et al.
Publicado: (2012)

Gene therapy in rheumatoid arthritis: how to target joint destruction?
por: Pap, Thomas, et al.
Publicado: (1999)

Hamster and Murine Models of Severe Destructive Lyme Arthritis
por: Munson, Erik, et al.
Publicado: (2012)

RANKL is a therapeutic target of bone destruction in rheumatoid arthritis
por: Tanaka, Sakae
Publicado: (2019)

Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice
por: Llop-Guevara, Alba, et al.
Publicado: (2015)

Secukinumab for rheumatology: development and its potential place in therapy
por: Koenders, Marije I, et al.
Publicado: (2016)

Rapidly Destructive Inflammatory Arthritis of the Hip
por: Shu, Jenny, et al.
Publicado: (2014)

Local IL-18 gene transfer prevents severe joint destruction in murine collagen-induced arthritis by induction of IL-4 and osteoprotegerin
por: Joosten, LAB, et al.
Publicado: (2005)

Cytokines Involved in the Pathogenesis of SSc and Problems in the Development of Anti-Cytokine Therapy
por: Shima, Yoshihito
Publicado: (2021)

Suppressor of cytokine signaling (SOCS)-3 gene transfer protects against collagen-induced arthritis
por: van de Loo, FAJ, et al.
Publicado: (2004)

Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines
por: Poznyak, Anastasia V., et al.
Publicado: (2021)

Immunocytokines: the long awaited therapeutic magic bullet in rheumatoid arthritis?
por: van de Loo, Fons A, et al.
Publicado: (2009)

Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis
por: Wäldele, Stefan, et al.
Publicado: (2015)

Cartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review
por: Tateiwa, Daisuke, et al.
Publicado: (2019)

New Insights into the Role of Synovial Fibroblasts Leading to Joint Destruction in Rheumatoid Arthritis
por: Matsuda, Kotaro, et al.
Publicado: (2023)

Th17 cytokines and arthritis
por: Lubberts, Erik
Publicado: (2010)

Overview: Destruction of the Extracellular Matrix in Rheumatoid Arthritis
por: Krane, Stephen
Publicado: (2000)

62. A case of destructive arthritis with nodules
por: Mekkayil, Babitha, et al.
Publicado: (2018)

Higher efficacy of anti-IL-6/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis
por: Roeleveld, Debbie M., et al.
Publicado: (2017)

Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis
por: Dancevic, Carolyn M, et al.
Publicado: (2014)

Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments
por: Maeda, Kazuhiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_oed96oh5s9bbi1sb9ju6gr65pj